Expert Panel Defines Premature Ejaculation
ORLANDO—For the first time, clinicians have an evidence-based definition of premature ejaculation (PE).
Print Issue: August 01, 2008
Combination Improves Renal Graft Function, Study Shows
TORONTO—Twelve-month results of the Spare-the-Nephron study show that a regimen that spares calcineurin inhibitors (CNI) can improve renal allograft function and glomerular filtration rate (GFR).
Experimental Drug Benefits Type 2 Diabetics
SAN FRANCISCO—New results from a phase III trial demonstrate that the investigational once-weekly formulation of exenatide, an incretin mimetic agent, provides sustained glucose control and weight loss for at least 52 weeks in patients with type 2 diabetes.
Bone Markers May Aid PCa Management
CHICAGO—Bone remodeling markers may be useful for diagnosing and following prostate and breast cancer patients with bone metastases, according to researchers.
Even Brief Lithium Exposure Can Harm
WASHINGTON, D.C.—Impaired renal function is a well-known side effect of lithium, which has been used since the 1950s to treat acute episodes of mania and as maintenance therapy for bipolar disorder. In the largest study to date of the renal effects of lithium, researchers found that the duration of lithium treatment did not correlate with glomerular filtration rate (GFR).
Bladder Trauma in Iraqi Civilians Examined
ORLANDO—Penetrating injuries from bullets or metal fragments from explosive devices are the most common cause of civilian bladder trauma in Iraq, according to Firas Ghanim Petros, MD, and his colleagues at Al Yarmouk Teaching Hospital, a major trauma center in Baghdad.
In Clinical Trials, Does One Size Fit All?
Practicing evidence-based medicine can be difficult in nephrology, where randomized controlled trials are few and far between. In general, the more that trials use hard outcomes such as morbidity and mortality, the greater our confidence that the therapies will have an impact on patients’ lives. Using end points such as these, however, often require large sample sizes.
Beta Blocker Meets Stricter Criterion
NEW ORLEANS—Two pooled analyses of the newest beta blocker, nebivolol, demonstrate that it is effective as once daily monotherapy in stage 1 and 2 hypertension using more stringent criteria than normal to measure BP control.
Baseline PSA Value Can Predict PCa Up to 30 Years Later
ORLANDO—Premalignant phases of prostate cancer occur over long periods of time and a single PSA measurement taken at age 44-50 can help predict prostate cancer diagnosis up to 30 years subsequently, according to updated findings from a study of Swedish men.
Antihypertensive Agents Found to Slow GFR Decline
TORONTO—Patients treated with antihypertensive agents experience slower declines in renal function, new data show.
- Loading...
Loading...
Next post in News
Loading... 
Loading...